These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 24498016

  • 21. Identification of circulating microRNA signatures for breast cancer detection.
    Chan M, Liaw CS, Ji SM, Tan HH, Wong CY, Thike AA, Tan PH, Ho GH, Lee AS.
    Clin Cancer Res; 2013 Aug 15; 19(16):4477-87. PubMed ID: 23797906
    [Abstract] [Full Text] [Related]

  • 22. PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.
    Bastien RR, Rodríguez-Lescure Á, Ebbert MT, Prat A, Munárriz B, Rowe L, Miller P, Ruiz-Borrego M, Anderson D, Lyons B, Álvarez I, Dowell T, Wall D, Seguí MÁ, Barley L, Boucher KM, Alba E, Pappas L, Davis CA, Aranda I, Fauron C, Stijleman IJ, Palacios J, Antón A, Carrasco E, Caballero R, Ellis MJ, Nielsen TO, Perou CM, Astill M, Bernard PS, Martín M.
    BMC Med Genomics; 2012 Oct 04; 5():44. PubMed ID: 23035882
    [Abstract] [Full Text] [Related]

  • 23. Plasma Circulating Mirnas Profiling for Identification of Potential Breast Cancer Early Detection Biomarkers.
    Jusoh AR, Mohan SV, Lu Ping T, Tengku Din TADAAB, Haron J, Romli RC, Jaafar H, Nafi SN, Tuan Salwani TI, Yahya MM.
    Asian Pac J Cancer Prev; 2021 May 01; 22(5):1375-1381. PubMed ID: 34048164
    [Abstract] [Full Text] [Related]

  • 24. Dysregulation of microRNA expression drives aberrant DNA hypermethylation in basal-like breast cancer.
    Sandhu R, Rivenbark AG, Mackler RM, Livasy CA, Coleman WB.
    Int J Oncol; 2014 Feb 01; 44(2):563-72. PubMed ID: 24297604
    [Abstract] [Full Text] [Related]

  • 25. Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.
    Schrauder MG, Strick R, Schulz-Wendtland R, Strissel PL, Kahmann L, Loehberg CR, Lux MP, Jud SM, Hartmann A, Hein A, Bayer CM, Bani MR, Richter S, Adamietz BR, Wenkel E, Rauh C, Beckmann MW, Fasching PA.
    PLoS One; 2012 Feb 01; 7(1):e29770. PubMed ID: 22242178
    [Abstract] [Full Text] [Related]

  • 26. Identification of microRNAs in Nipple Discharge as Potential Diagnostic Biomarkers for Breast Cancer.
    Zhang K, Zhao S, Wang Q, Yang HS, Zhu J, Ma R.
    Ann Surg Oncol; 2015 Dec 01; 22 Suppl 3():S536-44. PubMed ID: 25976861
    [Abstract] [Full Text] [Related]

  • 27. Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival.
    Ihemelandu CU, Leffall LD, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH, Adams-Campbell L, Frederick WA.
    J Surg Res; 2007 Nov 01; 143(1):109-18. PubMed ID: 17950079
    [Abstract] [Full Text] [Related]

  • 28. Correlation of miRNA expression profiling in surgical pathology materials, with Ki-67, HER2, ER and PR in breast cancer patients.
    Sakurai M, Masuda M, Miki Y, Hirakawa H, Suzuki T, Sasano H.
    Int J Biol Markers; 2015 May 26; 30(2):e190-9. PubMed ID: 25907662
    [Abstract] [Full Text] [Related]

  • 29. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
    Wu Q, Guo L, Jiang F, Li L, Li Z, Chen F.
    J Cell Mol Med; 2015 Dec 26; 19(12):2874-87. PubMed ID: 26416600
    [Abstract] [Full Text] [Related]

  • 30. Serum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohort.
    Godfrey AC, Xu Z, Weinberg CR, Getts RC, Wade PA, DeRoo LA, Sandler DP, Taylor JA.
    Breast Cancer Res; 2013 May 24; 15(3):R42. PubMed ID: 23705859
    [Abstract] [Full Text] [Related]

  • 31. Meta-microRNA Biomarker Signatures to Classify Breast Cancer Subtypes.
    Oztemur Islakoglu Y, Noyan S, Aydos A, Gur Dedeoglu B.
    OMICS; 2018 Nov 24; 22(11):709-716. PubMed ID: 30388053
    [Abstract] [Full Text] [Related]

  • 32. Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.
    Matamala N, Vargas MT, González-Cámpora R, Miñambres R, Arias JI, Menéndez P, Andrés-León E, Gómez-López G, Yanowsky K, Calvete-Candenas J, Inglada-Pérez L, Martínez-Delgado B, Benítez J.
    Clin Chem; 2015 Aug 24; 61(8):1098-106. PubMed ID: 26056355
    [Abstract] [Full Text] [Related]

  • 33. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL, Ren LF, Wang HP, Bai ZT, Zhang L, Meng WB, Zhu KX, Ding FH, Miao L, Yan J, Wang YP, Liu YQ, Zhou WC, Li X.
    World J Gastroenterol; 2019 Apr 07; 25(13):1580-1591. PubMed ID: 30983818
    [Abstract] [Full Text] [Related]

  • 34. Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers.
    van Schooneveld E, Wouters MC, Van der Auwera I, Peeters DJ, Wildiers H, Van Dam PA, Vergote I, Vermeulen PB, Dirix LY, Van Laere SJ.
    Breast Cancer Res; 2012 Feb 21; 14(1):R34. PubMed ID: 22353773
    [Abstract] [Full Text] [Related]

  • 35. Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.
    Xiao B, Zhang W, Chen L, Hang J, Wang L, Zhang R, Liao Y, Chen J, Ma Q, Sun Z, Li L.
    Gene; 2018 Jun 05; 658():28-35. PubMed ID: 29518546
    [Abstract] [Full Text] [Related]

  • 36. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y, Sui J, Shen X, Li C, Yao W, Hong W, Peng H, Pu Y, Yin L, Liang G.
    Oncol Rep; 2017 Jun 05; 37(6):3543-3553. PubMed ID: 28498428
    [Abstract] [Full Text] [Related]

  • 37. Underexpression of circulating miR-145-5p and miR-133a-3p are associated with breast cancer and immunohistochemical markers.
    García-Magallanes N, Beltran-Ontiveros SA, Leal-León EA, Luque-Ortega F, Romero-Quintana JG, Osuna-Ramirez I, Barbosa-Jasso M, Arámbula-Meraz E.
    J Cancer Res Ther; 2020 Jun 05; 16(6):1223-1228. PubMed ID: 33342777
    [Abstract] [Full Text] [Related]

  • 38. Aberrant miRNAs expressed in HER-2 negative breast cancers patient.
    Braicu C, Raduly L, Morar-Bolba G, Cojocneanu R, Jurj A, Pop LA, Pileczki V, Ciocan C, Moldovan A, Irimie A, Eniu A, Achimas-Cadariu P, Paradiso A, Berindan-Neagoe I.
    J Exp Clin Cancer Res; 2018 Oct 20; 37(1):257. PubMed ID: 30342533
    [Abstract] [Full Text] [Related]

  • 39. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
    Chen X, Wang YW, Zhu WJ, Li Y, Liu L, Yin G, Gao P.
    Hum Pathol; 2018 Jun 20; 76():122-132. PubMed ID: 29555574
    [Abstract] [Full Text] [Related]

  • 40. Integrated microRNA and mRNA signatures associated with survival in triple negative breast cancer.
    Cascione L, Gasparini P, Lovat F, Carasi S, Pulvirenti A, Ferro A, Alder H, He G, Vecchione A, Croce CM, Shapiro CL, Huebner K.
    PLoS One; 2013 Jun 20; 8(2):e55910. PubMed ID: 23405235
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.